EchoGo® Heart Failure vs Viz HCM
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (EchoGo® Heart Failure) and Tool B (Viz HCM) are adjacent competitors in the cardiology AI space, addressing distinct cardiac conditions. EchoGo® Heart Failure specializes in detecting Heart Failure with preserved Ejection Fraction (HFpEF) through echocardiogram analysis. Conversely, Viz HCM focuses on identifying suspected Hypertrophic Cardiomyopathy (HCM) using real-time ECG analysis and coordinating subsequent care.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. Viz HCM focuses on the real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) through ECG analysis.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips to provide insights for HFpEF detection. In contrast, Viz HCM utilizes real-time electrocardiogram (ECG) analysis to detect suspected Hypertrophic Cardiomyopathy.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T, with a national Medicare average of $316 per analysis. Viz HCM offers CMS reimbursement through CPT codes 0764T and 0765T, with a national payment rate of $128.90 effective January 1, 2025.
EchoGou00ae Heart Failure provides insights for HFpEF detection within 20 minutes of analyzing echocardiogram video clips. Viz HCM offers real-time disease detection from electrocardiograms, along with immediate mobile-based alerts.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF, trained on over 10 years of outcome data. Viz HCM is clinically validated with extensive real-world evidence and publications.
EchoGou00ae Heart Failure delivers automated structured reports for HFpEF detection via DICOM workflow to PACS. Viz HCM provides mobile-based alerts and notifications to multidisciplinary care teams, and automates the direction of patients to appropriate care specialists for suspected HCM.